Comprehensive and accurate Phentermine side effects information for consumers and healthcare professionals.

The combination of the drugs phentermine and topiramate (trade name Qnexa) is an investigational medication for the treatment of obesity and related conditions such as type 2 ...

1. Lancet. 2011 Apr 16;377(9774):1341-52. Epub 2011 Apr 8. Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated ...

Diet drugs may have side effects, and while drugs cannot take the place of diet and exercise, drugs like phentermine and topiramate do aid with weight loss study finds.

Topiramate (brand name Topamax) is an anticonvulsant (antiepilepsy) drug. It was originally produced by Ortho-McNeil Neurologics and Noramco, Inc., both divisions of the ...

UK Medicines Information for NHS professionals ... Trade Name: Qnexa : Entry Type: New formulation : Developmental Status: UK: Pre-registration (Filed)

SILVER SPRING, Md. -- A US Food and Drug Administration advisory committee voted overwhelmingly this afternoon in favor of approving the anti-obesity drug Qnexa. It ...

1. Am J Clin Nutr. 2012 Feb;95(2):297-308. Epub 2011 Dec 7. Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and ...

TOPAMAX SUMMARY TOPAMAX ® (topiramate) Tablets TOPAMAX ® (topiramate capsules) Sprinkle Capsules. Topiramate is a sulfamate-substituted monosaccharide that is intended for ...

Topiramate - Topiramate is a seizure medication, also called an anticonvulsant. - Seek emergency medical attention if you have a sudden change in vision or pain around or ...

Compare Obesity medications. Comprehensive Obesity drug options for consumers and professionals including user ratings, reviews and drug dosage information.

The latest developments in cardiology and cardiovascular research, including heartwire news and commentary by some of the world's top cardiologists. Sign up for free.

VIVUS, Inc. is a drug-development company dedicated to the development and commercialization of next-generation therapeutic products addressing obesity and sexual health.

Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised ...

Only 1% of Adults take Diet Pills. A study in the medical journal Obesity came out with some startling facts: less than 1% of people used medicines for obesity, despite the ...

LOS OSOS, Calif. — Next week, advisers to the Food and Drug Administration will recommend whether the agency should approve the first new prescription diet pill in ...